291 related articles for article (PubMed ID: 9589349)
1. Genetic alterations in mouse lung tumors: implications for cancer chemoprevention.
Herzog CR; Lubet RA; You M
J Cell Biochem Suppl; 1997; 28-29():49-63. PubMed ID: 9589349
[TBL] [Abstract][Full Text] [Related]
2. Genetic markers for early detection of lung cancer and outcome measures for response to chemoprevention.
Wiest JS; Franklin WA; Drabkin H; Gemmill R; Sidransky D; Anderson MW
J Cell Biochem Suppl; 1997; 28-29():64-73. PubMed ID: 9589350
[TBL] [Abstract][Full Text] [Related]
3. Mice with alterations in both p53 and Ink4a/Arf display a striking increase in lung tumor multiplicity and progression: differential chemopreventive effect of budesonide in wild-type and mutant A/J mice.
Wang Y; Zhang Z; Kastens E; Lubet RA; You M
Cancer Res; 2003 Aug; 63(15):4389-95. PubMed ID: 12907609
[TBL] [Abstract][Full Text] [Related]
4. Molecular genetics of small cell lung carcinoma.
Wistuba II; Gazdar AF; Minna JD
Semin Oncol; 2001 Apr; 28(2 Suppl 4):3-13. PubMed ID: 11479891
[TBL] [Abstract][Full Text] [Related]
5. A strong candidate gene for the Papg1 locus on mouse chromosome 4 affecting lung tumor progression.
Zhang Z; Wang Y; Herzog CR; Liu G; Lee HW; DePinho RA; You M
Oncogene; 2002 Aug; 21(38):5960-6. PubMed ID: 12185599
[TBL] [Abstract][Full Text] [Related]
6. Cancer chemopreventive activity of a mixture of Chinese herbs (antitumor B) in mouse lung tumor models.
Zhang Z; Wang Y; Yao R; Li J; Yan Y; La Regina M; Lemon WL; Grubbs CJ; Lubet RA; You M
Oncogene; 2004 May; 23(21):3841-50. PubMed ID: 15021904
[TBL] [Abstract][Full Text] [Related]
7. Genetic and epigenetic alterations in lung tumors from bitransgenic Ki-rasG12C expressing mice.
Floyd HS; Jennings-Gee JE; Kock ND; Miller MS
Mol Carcinog; 2006 Jul; 45(7):506-17. PubMed ID: 16482519
[TBL] [Abstract][Full Text] [Related]
8. Molecular profiling of mouse lung tumors: association with tumor progression, lung development, and human lung adenocarcinomas.
Bonner AE; Lemon WJ; Devereux TR; Lubet RA; You M
Oncogene; 2004 Feb; 23(5):1166-76. PubMed ID: 14647414
[TBL] [Abstract][Full Text] [Related]
9. Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor gene.
Tao Q; Fujimoto J; Men T; Ye X; Deng J; Lacroix L; Clifford JL; Mao L; Van Pelt CS; Lee JJ; Lotan D; Lotan R
J Natl Cancer Inst; 2007 Nov; 99(22):1668-82. PubMed ID: 18000218
[TBL] [Abstract][Full Text] [Related]
10. Carcinogen-specific targeting of chromosome 12 for loss of heterozygosity in mouse lung adenocarcinomas: implications for chromosome instability and tumor progression.
Herzog CR; Bodon N; Pittman B; Maronpot RR; Massey TE; Anderson MW; You M; Devereux TR
Oncogene; 2004 Apr; 23(17):3033-9. PubMed ID: 14755239
[TBL] [Abstract][Full Text] [Related]
11. Prevention of lung cancer progression by bexarotene in mouse models.
Wang Y; Zhang Z; Yao R; Jia D; Wang D; Lubet RA; You M
Oncogene; 2006 Mar; 25(9):1320-9. PubMed ID: 16247446
[TBL] [Abstract][Full Text] [Related]
12. Tumor suppressor genes in human lung cancer.
Shimizu E; Sone S
J Med Invest; 1997 Aug; 44(1-2):15-24. PubMed ID: 9395713
[TBL] [Abstract][Full Text] [Related]
13. Allelotype analysis of mouse lung carcinomas reveals frequent allelic losses on chromosome 4 and an association between allelic imbalances on chromosome 6 and K-ras activation.
Hegi ME; Devereux TR; Dietrich WF; Cochran CJ; Lander ES; Foley JF; Maronpot RR; Anderson MW; Wiseman RW
Cancer Res; 1994 Dec; 54(23):6257-64. PubMed ID: 7954475
[TBL] [Abstract][Full Text] [Related]
14. Molecular pathogenesis of pituitary tumors.
Farrell WE; Clayton RN
Front Neuroendocrinol; 2000 Jul; 21(3):174-98. PubMed ID: 10882539
[TBL] [Abstract][Full Text] [Related]
15. [Application of molecular diagnosis to human lung cancer].
Isobe T
Rinsho Byori; 1995 Aug; 43(8):792-8. PubMed ID: 7474438
[TBL] [Abstract][Full Text] [Related]
16. A mouse model for tumor progression of lung cancer in ras and p53 transgenic mice.
Wang Y; Zhang Z; Lubet RA; You M
Oncogene; 2006 Feb; 25(8):1277-80. PubMed ID: 16247444
[TBL] [Abstract][Full Text] [Related]
17. [Genetic alterations in the genesis and development of ovarian cancer].
Okamoto A; Yokoyama S; Terashima Y
Gan To Kagaku Ryoho; 1992 Oct; 19(12):1971-6. PubMed ID: 1358031
[TBL] [Abstract][Full Text] [Related]
18. Identification of Las2, a major modifier gene affecting the Pas1 mouse lung tumor susceptibility locus.
Liu PY; Vikis H; James M; Lu Y; Wang DL; Liu HB; Wen WD; Wang Y; You M
Cancer Res; 2009 Aug; 69(15):6290-8. PubMed ID: 19622765
[TBL] [Abstract][Full Text] [Related]
19. Cytogenetics and molecular genetics of lung cancer.
Mitsuuchi Y; Testa JR
Am J Med Genet; 2002 Oct; 115(3):183-8. PubMed ID: 12407699
[TBL] [Abstract][Full Text] [Related]
20. Molecular genetic alterations as intermediate end points in chemoprevention studies.
Conti CJ; Gimenez-Conti IB
IARC Sci Publ; 1996; (139):249-60. PubMed ID: 8923035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
